Quarterly report pursuant to Section 13 or 15(d)

Fraunhofer Settlement (Narrative) (Details)

v3.23.1
Fraunhofer Settlement (Narrative) (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 09, 2022
May 04, 2021
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2022
Mar. 01, 2023
Jun. 30, 2022
Mar. 01, 2022
Jun. 30, 2021
Settlement receivable - current portion             $ 5,100,000    
Revenues     $ 0 $ 1,800,000 $ 1,884,000        
Restricted cash     3,253,000       $ 5,996,000    
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member]                  
Cash payments receivables related to litigation settlement                 $ 10,200,000
Percentage of legal fees expected to be received   100.00%              
Estimated net cash recovery   $ 10,200,000              
Settlement payment received       5,100,000          
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | License and Maintenance [Member]                  
Settlement income $ 1,800,000                
Settlement payment received $ 900,000                
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario, Plan [Member]                  
Cash payments receivables related to litigation settlement   28,000,000              
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Legal Fees [Member]                  
Cash payments receivables related to litigation settlement   $ 16,000,000              
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment One [Member]                  
Cash payments receivables related to litigation settlement               $ 900,000  
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment One [Member] | License and Maintenance [Member]                  
Settlement receivable - current portion       $ 5,100,000 $ 5,100,000        
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment Two [Member]                  
Cash payments receivables related to litigation settlement           $ 900,000      
iBio, Inc. v. Fraunhofer USA, Inc. [Member] | Settled Litigation [Member] | Scenario Plan Expected Payment Two [Member] | License and Maintenance [Member]                  
Settlement receivable - noncurrent portion     $ 5,100,000